Literature DB >> 15532983

VTEC O157 subtypes associated with the most severe clinical symptoms in humans constitute a minor part of VTEC O157 isolates from Danish cattle.

Bent Bjørn Roldgaard1, Flemming Scheutz, Jeppe Boel, Søren Aabo, Anna Charlotte Schultz, Tom Cheasty, Eva Møller Nielsen, Katharina E P Olsen, Bjarke Bak Christensen.   

Abstract

The aim of this study was to compare the distribution of VTEC O157 subtypes isolated from human sporadic infections with those in the Danish bovine reservoir, and to correlate the subtypes with the severity of the clinical symptoms in humans. The study included a total of 149 Danish eae-positive VTEC O157 isolates (63 of bovine origin and 86 from human clinical cases) isolated between 1987 and 2001. All were analysed by vtx-PCR-RFLP and phage typing. The vtx-PCR-RFLP showed that isolates carrying the vtx2 gene was more than four times as prevalent among the human clinical isolates (55%) as compared to the bovine isolates (13%). Furthermore, a significant correlation between the presence of the vtx2 gene and development of haemolytic-uraemic syndrome was found. The 149 isolates encompassed 16 different phage types (PTs). The majority (87%) of the human clinical isolates were identified, as PT2, PT4, PT8 or PT14 while only 46% of the bovine isolates belonged to these PTs. PT8 and PT14 were found at similar rates among bovine (36%) and human isolates (40%). However, the predominant PTs in the human isolates, PT2 (19%) and PT4 (28%), were only identified in 2% and 8%, respectively, of the bovine isolates. All but one PT2 and PT4 isolate carried either vtx2 alone or in combination with vtx2c, whereas none of the PT8 and PT14 isolates carried vtx2. The significant overlap between vtx/phage type combinations in bovine and human clinical isolates indicate that cattle are an important reservoir for human VTEC O157 infections in Denmark. However, the vtx2-carrying isolates, causing the most severe clinical symptoms, constitute only a minor fraction of the isolates from the Danish bovine reservoir.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532983     DOI: 10.1016/j.ijmm.2004.05.001

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  8 in total

1.  Hfq virulence regulation in enterohemorrhagic Escherichia coli O157:H7 strain 86-24.

Authors:  Melissa M Kendall; Charley C Gruber; David A Rasko; David T Hughes; Vanessa Sperandio
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

2.  Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.

Authors:  Søren Persson; Katharina E P Olsen; Steen Ethelberg; Flemming Scheutz
Journal:  J Clin Microbiol       Date:  2007-04-19       Impact factor: 5.948

Review 3.  Escherichia coli O157:H7: animal reservoir and sources of human infection.

Authors:  Witold A Ferens; Carolyn J Hovde
Journal:  Foodborne Pathog Dis       Date:  2010-11-30       Impact factor: 3.171

4.  Molecular risk assessment and epidemiological typing of Shiga toxin-producing Escherichia coli by using a novel PCR binary typing system.

Authors:  Stephanie M Brandt; Nicola King; Angela J Cornelius; Aruni Premaratne; Thomas E Besser; Stephen L W On
Journal:  Appl Environ Microbiol       Date:  2011-02-04       Impact factor: 4.792

5.  Verotoxigenic Escherichia coli O157:H7 from Swedish cattle; isolates from prevalence studies versus strains linked to human infections--a retrospective study.

Authors:  Anna Aspán; Erik Eriksson
Journal:  BMC Vet Res       Date:  2010-01-29       Impact factor: 2.741

6.  Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains.

Authors:  Kim Ziebell; Marina Steele; Yongxiang Zhang; Andrew Benson; Eduardo N Taboada; Chad Laing; Scott McEwen; Bruce Ciebin; Roger Johnson; Victor Gannon
Journal:  Appl Environ Microbiol       Date:  2008-05-16       Impact factor: 4.792

7.  Phylogeny of Shiga toxin-producing Escherichia coli O157 isolated from cattle and clinically ill humans.

Authors:  James L Bono; Timothy P L Smith; James E Keen; Gregory P Harhay; Tara G McDaneld; Robert E Mandrell; Woo Kyung Jung; Thomas E Besser; Peter Gerner-Smidt; Martina Bielaszewska; Helge Karch; Michael L Clawson
Journal:  Mol Biol Evol       Date:  2012-02-21       Impact factor: 16.240

8.  Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.

Authors:  N Launders; L Byrne; C Jenkins; K Harker; A Charlett; G K Adak
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.